Epidemiology of Trachoma: A Report by Sitapur Trachoma Study Group

Deepak Mishra

doi:10.4172/2155-9570.1000336

Abstract

Trachoma is the most common cause of infectious blindness worldwide and it affects more than 150 million people. Despite of various control programs, it still persists and lead to significant ocular morbidity. We have done Prospective clinical epidemiological study conducted at Regional Institute of Ophthalmology (RIO) & Sitapur Eye Hospital (SHE), Sitapur, Uttar Pradesh, India. RIO & SEH is a large tertiary care hospital working with community since 1935 and serves more than 32 cities and towns in the states of Uttranchal and Uttar Pradesh of India and rest of its 32 branches all over. Cases were selected from our OPD clinic and findings were verified by 2 independent ophthalmologists. Percentage of patients with fresh cases / active trachoma- 64 and percentage of patients with active on chronic / old trachoma- 36.7%. Trachoma remains still an unconquered scourge.

Highlights

Trachoma is the most common cause of infectious blindness worldwide and it affects more than 150 million people, with 10 million people developing secondary trichiasis and approximately 6 million blinded from the squeal of the disease across the globe [1]
A Prospective clinical epidemiological study conducted at Regional Institute of Ophthalmology (RIO) & Sitapur Eye Hospital (SHE), Sitapur, Uttar Pradesh, India
RIO & SEH is a large tertiary care hospital working with community since 1935 and serves more than 32 cities and towns in the states of Uttranchal and Uttar Pradesh of India

Summary

Introduction

Trachoma is the most common cause of infectious blindness worldwide and it affects more than 150 million people, with 10 million people developing secondary trichiasis and approximately 6 million blinded from the squeal of the disease across the globe [1]. It is third most common cause of blindness worldwide after cataract and glaucoma [2]. In India the prevalence has decreased drastically from the levels in early 60s when National program of control of trachoma was launched in 1963, but the disease still persists, causing significant visual morbidity

Methods

Results

Conclusion